CRISPR THERAPEUTICS AG Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
CRISPR THERAPEUTICS AG (CRSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 69.20% for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2019-10-28
- CRISPR THERAPEUTICS AG share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2019-03-31 was 69.30%, a 1.70% decline year-over-year.
- CRISPR THERAPEUTICS AG share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2018-03-31 was 70.50%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month |
|---|---|---|---|
| 2019-09-30 | 69.20% 10-Q · filed 2019-10-28 | ||
| 2019-06-30 | 69.30% 10-Q · filed 2019-07-29 | ||
| 2019-03-31 | 69.30% 10-Q · filed 2019-04-29 | ||
| 2018-09-30 | 71.90% 10-Q · filed 2019-10-28 | ||
| 2018-06-30 | 72.20% 10-Q · filed 2019-07-29 | ||
| 2018-03-31 | 70.50% 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |